Close

CMS Adds Veltassa to CY16 Formulary Reference File; H.C. Wainwright Affirms Relypsa (RLYP) at 'Buy'

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/23/2024

1. GM
2. TSLA
3. SPY
4. NVDA
5. ADBE
6. MTTR
7. CPRI
8. CDNS
9. VERX
10. RIL:IN


Go back to CMS Adds Veltassa to CY16 Formulary Reference File; H.C. Wainwright Affirms Relypsa (RLYP) at 'Buy'
RELYPSA (NASDAQ: RLYP) Delayed: 31.99 --0 (-0%)
Previous Close $31.99    52 Week High $32.12 
Open $3.07    52 Week Low $10.26 
Day High $31.99    P/E N/A 
Day Low $31.99    EPS $-4.54 
Volume 79,870